As hospitals and health systems work to develop population health strategies to better serve their communities and rein in the overall cost of care, behavioral health patients cannot be ignored.
Behavioral health patients have higher-than-average rates of emergency department visits, hospitalizations, and readmissions. To make behavioral health a core part of its population health strategy, one Ohio health system is partnering with a mental health services provider.
As hospitals and health systems work to develop population health strategies to better serve their communities and rein in the overall cost of care, behavioral health patients—who have higher-than-average rates of emergency department visits, hospitalizations, and readmissions—cannot be ignored.
These individuals make up a large subset of the patient population. According to the Substance Abuse and Mental Health Services Administration's 2012 National Survey on Drug Use and Health, 43.7 million (18.6%) US adults experienced some form of mental illness that year. Additionally, 20.7 million adults (8.8%) had a substance use disorder, and of those, 8.4 million people had both a mental disorder and a substance abuse disorder.
Read more at HealthLeaders Media: http://bit.ly/1GORdWs
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More